Evidence map›Paper›PMID 29523593›Full record

ArticleJournal of the American Society of Nephrology : JASN2018

Evaluation of Potential Living Kidney Donors in the

Barry I Freedman, Bruce A Julian

Registry-linked trialAbstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03615235 (APOL1 Long-term Kidney Transplantation Outcomes Network), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03615235 active not recruitingnot on this mapstarted 2019, after this paper: background citation

APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)

TypeobservationalSponsorWake Forest University Health SciencesRan2019 to 2027Enrolled5,000ConditionsKidney Diseases, Kidney Failure, Kidney Disease, Chronic
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Opinions of African American adults about the use of apolipoprotein L1 (ApoL1) genetic testing in living kidney donation and transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  2. Apolipoprotein L1: role in the evaluation of kidney transplant donors.Current opinion in nephrology and hypertension · 2020
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

  • Comment on
    2018
5 · Who and what money

Authors and funding

2 authors.

Barry I FreedmanDepartment of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina; and bfreedma@wakehealth.edu.
Bruce A JulianDepartment of Medicine, Division of Nephrology; University of Alabama at Birmingham School of Medicine, Birmingham, Alabama.

Funding

Wake Forest APOLLO Scientific and Data Research CenterU01DK116041 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Nicholette D. Allred, BARRY Ira FREEDMAN · 2017 to 2026
$8.7M
Genetic Analysis of African American Hypertensive End-Stage Renal DiseaseR01DK070941 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FREEDMAN, BARRY IRA · 2006 to 2015
$4.7M
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical CenterU01DK115997 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Gaurav Agarwal, ROSLYN B MANNON · 2017 to 2026
$2.4M
Natural History of MYH9-Associated NephropathyR01DK084149 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FREEDMAN, BARRY IRA · 2009 to 2012
$2.3M
NIDDK NIH HHS R01 DK070941NIDDK NIH HHS R01 DK084149NIDDK NIH HHS U01 DK115997NIDDK NIH HHS U01 DK116041
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Kidney TransplantationLiving DonorsApolipoprotein L1GenotypeHumansKidneyAPOL1 protein, humanApolipoprotein L1African AmericanAPOL1chronic kidney diseasekidney donationsafetytransplantation

Identifiers

PMID29523593
PMCPMC5875967

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.